Navigation Links
BD Launches Family of Syringes Which Addresses Environmental Impact and Meets a Variety of Clinical Needs
Date:8/15/2011

FRANKLIN LAKES, N.J., Aug. 15, 2011 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson and Company), today announced the launch of the BD Emerald™ Syringe portfolio designed to meet emerging needs in medication delivery while addressing environmental impact by reducing material. The BD Emerald Syringe portfolio includes the BD Emerald™ Conventional Syringe for general medication preparation and delivery, the BD Emerald Saf-T™ Syringe with a shielding mechanism to protect against needlesticks and the BD Emerald PRO™ Reuse Prevention Syringe featuring a passive locking system to prevent reuse.

The BD Emerald product family is designed sustainably with input from clinicians around the world. The product family is also supported by the Company's long-standing history and commitment to developing first-class injection devices supported by clinical education programs to improve the delivery of healthcare. The BD Emerald Syringes will be manufactured at facilities in Spain, India and Brazil, utilizing sustainable manufacturing practices, including 100 percent renewable electricity for production where available. The syringes meet the International Organization and Standardization requirements, and satisfy local registration standards.

“BD recognizes that human health and a healthy environment are inseparable,” said Bill Kozy, Executive Vice President, BD. “We are committed to responsible environmental stewardship in our business conduct. The BD Emerald Syringes meet our highest standards for product quality while also reducing environmental impact by using sustainable operations practices and less material.”

The BD Emerald Syringe family offers features to prevent the spread of infection, address environmental impact, address clinical needs and meet quality standards around the world:

  • BD Emerald Saf-T Syringe is designed to address the needs of healthcare workers who require protection from needlestick injuries.
  • BD Emerald PRO is designed to address the needs of the developing world. The infection control issue at the forefront of healthcare delivery in these regions is preventing reuse of injection devices and the potential spread of pathogens from patient to patient.
  • All syringes in the BD Emerald Syringe product family are designed to reduce medical waste effects in communities everywhere.

The BD Emerald Syringe product line builds upon BD's sustainability commitment, which has been recognized for achievements in environmental stewardship. In Newsweek's 2010 "Green Rankings" of the 500 largest U.S. corporations, BD ranked second in the Healthcare sector and 24th overall. As part of its commitment to sustainability, BD's worldwide headquarters and three of BD's U.S. manufacturing sites are offsetting 100 percent of their electricity use with renewable energy through green power purchases and renewable energy credits. To learn more about environmental stewardship at BD, visit www.bd.com/sustainability.

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

Contact:
Barbara Kalavik
Public Relations
(201) 847-4209
Barbara_Kalavik@bd.com


'/>"/>
SOURCE BD-Becton Dickinson
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Mylan Launches Generic Version of Uroxatral® Tablets
2. Providian Medical Launches New Tool to Make Finding the Right Ultrasound Machine Easier Than Ever
3. Elsevier Launches Next Generation Codifa, Providing Italian Doctors with Real Time Access to Critical Drug Information
4. R A E N Optics Launches New Website and Releases New Styles
5. Evergreen Hospital Launches Revolutionary Breast Cancer Detection and Diagnostic Imaging Technology
6. Lilly Launches Physician Payment Registry
7. Concentric Medical Launches DAC® 070, A New Distal Access Catheter
8. Success Factors and Failure Points for Oncology New Product Launches
9. Ortho Clinical Diagnostics Launches VITROS® 4600 Chemistry System for Mid- to High-Volume Laboratories
10. Ortho Clinical Diagnostics Launches VITROS 4600® Chemistry System for Mid- to High-Volume Laboratories
11. Actavis Launches Oxymorphone Hydrochloride Extended-Release Tablets, CII in the U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... TREE, Colo. , March 29, 2017  Zynex (OTCQB: ... manufacture and sale of non-invasive medical devices for pain ... today that it will host the Company,s 2016 full-year ... a.m. Eastern Time.) The Company expects to ... 31, 2017. ...
(Date:3/29/2017)... , March 29, 2017 According to a new ... Type (Gas-Filled Detectors, Geiger Muller, Survey Meter, Solid-State), Products (Personal Dosimeters, OSL, ... 2021" published by MarketsandMarkets, the market is expected to reach USD 1,215.4 ... of 6.5% from 2016 to 2021. Continue ... ...
(Date:3/29/2017)... , March 29, 2017  The Pharmaceutical Care ... a new PhRMA report on patient out-of-pocket spending: ... Medicare and Medicaid Services (CMS), the average amount spent ... 13% of drug spending in 2016, down from 23% ... a pricing problem, not a coverage problem. Health plans ...
Breaking Medicine Technology:
(Date:3/30/2017)... NC (PRWEB) , ... March 30, 2017 , ... ... will host the live audio conference “ Preventing Hospital Readmissions Through Discharge Planning ... 12, 2017 at 1:00 pm ET. This conference discusses strategies to prevent readmissions ...
(Date:3/29/2017)... ... 2017 , ... In the United States alone, up to 36% of primary ... of metastatic brain tumors(3). Though most meningiomas are benign, metastatic brain tumors are known ... effective treatment options, the San Diego Gamma Knife Center offers a precision-medicine ...
(Date:3/29/2017)... ... March 30, 2017 , ... CHARM CITY RUN WELCOMES MERCY MEDICAL CENTER ... Mercy Medical Center will serve as the official title sponsor of the Baltimore Women’s ... 25, 2017, thousands of women will walk or run the course around the Baltimore ...
(Date:3/29/2017)... ... March 29, 2017 , ... Wells Pharmacy Network, a ... at the upcoming World Congress, in Hollywood Florida April 6-8, 2017. , Ben ... the visionary leader in the training of physicians, scientists, and members of the ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... FASTBRACES® in Carnegie, OK, from Dr. Jamie Cameron, with or without a ... compared to traditional orthodontic treatment. Depending on each patient’s case, treatment with the ...
Breaking Medicine News(10 mins):